Evidence map›Paper›PMID 29226271›Full record

ArticleCurrent opinion in biomedical engineering2017

Clusters of Circulating Tumor Cells: a Biophysical and Technological Perspective.

Sam H Au, Jon Edd, Daniel A Haber, Shyamala Maheswaran, Shannon L Stott, Mehmet Toner

Abstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Liquid biopsy in bladder cancer: towards precision oncology.Journal of translational medicine · 2026
    Review
  2. Article
  3. Review
  4. Mechanical signatures in cancer metastasis.npj biological physics and mechanics · 2025
    Review
  5. Unique Cohorts of Salivary Gland Cancer Cells as anJournal of maxillofacial and oral surgery · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Mechanisms of breast cancer metastasis.Clinical & experimental metastasis · 2022
    Review
  14. Review
  15. Collective metastasis: coordinating the multicellular voyage.Clinical & experimental metastasis · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. BRAF Mutation Heterogeneity in Melanoma Lesions.Acta dermato-venereologica · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sam H AuCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Jon EddCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Daniel A HaberMassachusetts General Hospital Center for Cancer Research, Harvard Medical School, Charlestown, MA 02129.
Shyamala MaheswaranDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Shannon L StottCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Mehmet TonerCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.

Funding

Point-of care Microfluidics for Early Detection of CancerU01EB012493 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A., TONER, MEHMET · 2010 to 2018
$19.6M
Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
NIBIB NIH HHS P41 EB002503NIBIB NIH HHS U01 EB012493
6 · The paper itself

Abstract

The vast majority of cancer associated deaths result from metastasis, yet the behaviors of its most potent cellular driver, circulating tumor cell clusters, are only beginning to be revealed. This review highlights recent advances to our understanding of tumor cell clusters with emphasis on enabling technologies. The importance of intercellular adhesions among cells in clusters have begun to be unraveled with the aid of promising microfluidic strategies for isolating clusters from patient blood. Due to their metastatic potency, the utility of circulating tumor cell clusters for cancer diagnosis, drug screening, precision oncology and as targets of antimetastatic therapeutics are being explored. The continued development of tools for exploring circulating tumor cell clusters will enhance our fundamental understanding of the metastatic process and may be instrumental in devising new strategies to suppress and eliminate metastasis.

Indexed as

antimetastatic therapeuticsbiomechanicsbiophysicscancercapturecirculating tumor cell clustersctmdrug screeningintercellular adhesionsisolationmetastasismicrofluidicsprecision medicinereviewtumor microemboli

Identifiers

PMID29226271
PMCPMC5720146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.